Kalveer Flora, MPharm: Experience With Biosimilars in Rheumatology

Kalveer Flora, MPharm, London North West University Healthcare National Health Service Trust, explains how rheumatology specialists have led the way in biosimilar adoption.


In terms of my specialty, which is rheumatology, I think rheumatology pharmacists and rheumatologists have actually led the way in adopting biosimilars, only because we’ve had so much experience with biosimilars compared with dermatologists and gastroenterologists. So I think the rheumatologists have really led the way in providing that real-world evidence, that confidence, that transferrable data.

Related Videos
Christine Baeder Smiling
Michael Kleinrock
Ian Henshaw
Ian Henshaw
Ryan Haumschild, PharmD
John Gabrielson
Ryan Haumschild, PharmD, MS, MBA
Ryan Haumdschild, PharmD
banner for the ophthalmology linkedin live event sponsored by the samsung bioepis in partnership with the center for biosimilars
Ryan Haumschild, PharmD
Related Content
© 2023 MJH Life Sciences

All rights reserved.